Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 35-43 , January 2003

Detection and characterization of leishmania antigens from an American cutaneous leishmaniasis vaccine for diagnosis of visceral leishmaniasis

  • Wanderley Almeida Ferreira

      Affiliations

    • Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
    • ,
  • Wilson Mayrink

      Affiliations

    • Department of Parasitology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
    • ,
  • Marcos Luiz dos Mares-Guia

      Affiliations

    • Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
    • ,
  • Carlos Alberto Pereira Tavares

      Affiliations

    • Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
    • Corresponding Author InformationCorresponding author. Fax: 55 31 34415963.

Received 20 February 2002 ,Accepted 19 August 2002.

References 

  1. Badaró R, Benson D, Eulálio MC, et al.  rK39 (a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis). J Infect Dis. 1996;173:758–761
  2. Berman JD. Human Leishmaniasis (clinical, diagnostic, and chemotherapeutic developments in the last 10 years). Clin Infect Dis. 1997;24:684–703
  3. Bradford MM. Rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein dye-binding. Anal Biochem. 1976;72:248–254
  4. Brito MEF, Mendonça MG, Gomes YM, Jardim ML, Abath FGC. Identification of potentially diagnostic Leishmania brasiliensis antigens in human cutaneous leishmaniasis by immunoblot assays. Clin Diag Lab Immun. 2000;7(2):318–321
  5. Burns MJ, Shreffler WG, Benson DR, Ghalib HW, Badaró R, Reed SG. Molecular characterization of a kinesin-related antigen of Leishmania chagasi with detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci USA. 1993;90:775–779
  6. Cabrera GPB, De-Silva VO, Da-Costa RT, et al.  The fucose-manose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brasil. A J Trop Med Hyg. 1999;61(5):196–301
  7. Cardenosa N, Riera C, Cortés P, March F, Portús M, Prats G. Detection and characterization by immunoblot analysis of potentially diagnostic Leishmania infantum polypeptides in human visceral leishmaniasis. Parasite Immunol. 1995;17:509–516
  8. Cohen, A. S., Meys, M., & Tarvin, T. L. (1989). The Pico.Tag® Method. A Manual of Advanced techniques for Amino Acid Analysis. Edited by Waters chromatography Division
  9. Da-Costa CA, Toledo VPCP, Genaro O, Willians P, Mayrink W. Montenegro skin-test evaluation of the composition and stability of the antigen preparation. Mem Inst Oswaldo Cruz. 1996;91:193–194
  10. Decker-Jackson JE, Honigberg BN. Glycoproteins released by Leishmania donovani. Immunological relationships with host and bacterial antigens and preliminary biochemical analysis. Protozoology. 1978;25:514–525
  11. Dubbois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28(3):350–356
  12. El-On J, Schnur CL, Greenblat CL. Leishmania donovani (physicochemical, immunological and biological characterization of excreted factor from promastigotes). Exp Parasit. 1979;47:254–269
  13. Fairbanks G, Steck TE, Wallach DFH. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochem. 1971;10(13):2606–2617
  14. Khalil EAG, El Hassan AM, Zijlstra EE, et al.  Autoclaved Leishmania major vaccine against visceral leishmaniasis (a randomized, double-blind, BCG-controlled trial in Sudan). Lancet. 2000;356:1565–1569
  15. Lowry OH, Rosebrough N, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275
  16. Martin SK, Thuita-Harun L, Adoyo-Adoyo M, Wasuna KMA. Diagnostic ELISA for visceral leishmaniasis based on antigen from media conditioned by Leishmania donovani promastigotes. Ann Trop Med Parasit. 1998;92(5):571–577
  17. Mary C, Lamouroux D, Dunan S, Quilici M. Western-blot analysis of antibodies to Leishmania infantum antigens (Potential of the 14 and 16 KDa antigens for diagnosis and epidemiological purposes). A J Trop Med Hyg. 1992;47(6):764–771
  18. Mayrink W, Da-Costa CA, Magalhães PA, et al.  Field trial against American Cutaneous Leishmaniasis. Trans R Soc Trop Med Hyg. 1979;73(4):385–387
  19. Montoya Y, Lean C, Toledo M, et al.  Recombinant antigens for specific and sensitive serodiagnosis of latin tegumentary Leishmaniasis. Trans R Soc Trop Med Hyg. 1997;91(6):674–676
  20. Nascimento E, Mayrink W, Da-Costa CA, et al.  Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infect Immun. 1990;58(7):2198–2203
  21. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem. 1980;105:361–363
  22. Palatnik CB, Borojevic R, Previato JO, Mendonça-Previato L. Inhibition of Leishmania donovani promastigotes internalization by chemically defined parasite glyconconjugate ligands. Infect Immun. 1989;57(3):754–763
  23. Palatnik-de-Souza CB, Gomes EM, Paraguai-de-Souza EM, Palatnik M, Luz K , Borojevic R. Leishmania donovani (titration of antibodies to fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis). Trans R Soc Trop Med Hyg. 1995;89:390–393
  24. Ray R, Ghose AC. Somatic and excretory polysaccharide antigens of Leishmania donovani promastigotes. Aust J Exp Biol Med Sci. 1985;66(4):411–422
  25. Semprevivo LH. Exometabolites of Leishmania donovani promastigotes I. Proc Soc Exp Biol Med. 1978;159:105–110
  26. Semprevivo LH, Honigberg BM. Exometabolites of Leishmania donovani promastigotes II. Spontaneous changes of exometabolites after isolation. Zeitschrift fur Parazitenkunde. 1980;62:201–211
  27. Silva SO, Pimenta JR, Macedo AM, Melo MN. Identification and characterization of Leishmania major like strains. Mem Inst Oswaldo Cruz. 1994;89(1):124
  28. Tavares CAP, de Rossi R, Payares G, Simpson AJG, McLaren DJ, Smithers SR. A monoclonal antibody raised against adult Schistosoma mansoni, which recognizes a surface antigen on schistosomula. Zeitschrift fur Parasitenkund. 1984;70:189–197
  29. Thomas MC, Longobardo MV, Carmelo E, et al.  Mapping of antigenic determinants of T cruzi kinetoplastide membrane protein-11. Identification of a linear epitope specifically recognized by human chagasic sera. Clin Exp Immunol. 2001;123:465–471
  30. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Nat Acad Sci USA. 1979;76:4350–4354
  31. Trujilo C, Ramirez R, Velez ID, Berberich C. The humoral immune response to the kinetoplastide membrane protein-11 in patients with American Leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping epitopes. Immun Lett. 1999;70(3):203–209
  32. Turco SJ, Descoteau A. The lipophosphoglycan of Leishmania parasites. Ann Rev Microbiol. 1992;46:65–94
  33. WHO. (1997). Leishmaniasis: Thirteenth Program Report. Special Program for Research and Training in Tropical Diseases. World Health Organ Pub, pp. 100

PII: S0732-8893(02)00475-3

doi: 10.1016/S0732-8893(02)00475-3

Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 35-43 , January 2003

Article Tools

* Image Usage & Resolution